These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 15935299)
1. Liver recipients harbouring anti-donor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: experience of one centre. Muro M; Marin L; Miras M; Moya-Quiles R; Minguela A; Sánchez-Bueno F; Bermejo J; Robles R; Ramírez P; García-Alonso A; Parrilla P; Alvarez-López MR Transpl Immunol; 2005 Jun; 14(2):91-7. PubMed ID: 15935299 [TBL] [Abstract][Full Text] [Related]
2. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry. Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675 [TBL] [Abstract][Full Text] [Related]
3. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility. Castillo-Rama M; Castro MJ; Bernardo I; Meneu-Diaz JC; Elola-Olaso AM; Calleja-Antolin SM; Romo E; Morales P; Moreno E; Paz-Artal E Liver Transpl; 2008 Apr; 14(4):554-62. PubMed ID: 18383092 [TBL] [Abstract][Full Text] [Related]
4. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation. Lee PC; Ozawa M Clin Transpl; 2007; ():219-26. PubMed ID: 18642453 [TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants. Billen EV; Christiaans MH; van den Berg-Loonen EM Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037 [TBL] [Abstract][Full Text] [Related]
14. Alloantibodies and the outcome of cadaver kidney allografts. Vasilescu ER; Ho EK; Colovai AI; Vlad G; Foca-Rodi A; Markowitz GS; D'Agati V; Hardy MA; Ratner LE; Suciu-Foca N Hum Immunol; 2006 Aug; 67(8):597-604. PubMed ID: 16916655 [TBL] [Abstract][Full Text] [Related]
15. Are preformed antibodies to biliary epithelial cells of clinical importance in liver transplantation? Ge X; Ericzon BG; Nowak G; öHrström H; Broomé U; Sumitran-Holgersson S Liver Transpl; 2003 Nov; 9(11):1191-8. PubMed ID: 14586881 [TBL] [Abstract][Full Text] [Related]
16. Analysis of positive kidney, heart, and liver transplant crossmatches reported to the Collaborative Transplant Study. Opelz G; Döhler B; Süsal C Hum Immunol; 2009 Aug; 70(8):627-30. PubMed ID: 19375469 [TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Lefaucheur C; Suberbielle-Boissel C; Hill GS; Nochy D; Andrade J; Antoine C; Gautreau C; Charron D; Glotz D Contrib Nephrol; 2009; 162():1-12. PubMed ID: 19001809 [TBL] [Abstract][Full Text] [Related]
18. [The prognostic significance of pre-existing lymphocytotoxic antibodies in cadaveric kidney allografts with a negative specific crossmatch]. Kharlamova LA; Zemlianitskaia TL; Makhlin NV; Iankovoĭ Urol Nefrol (Mosk); 1993; (4):30-2. PubMed ID: 8310563 [TBL] [Abstract][Full Text] [Related]
19. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL; Jin XB; Li XT; Wang HW; Lü JJ Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748 [TBL] [Abstract][Full Text] [Related]
20. Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-up. Lachmann N; Terasaki PI; Schönemann C Clin Transpl; 2006; ():171-99. PubMed ID: 18365377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]